80
views
0
recommends
+1 Recommend
4 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The WHO Africa Region is experiencing an increase in the number of novel COVID-19 cases. As of May 20, 2020, 63,521 cases with 1,796 deaths (2.8% case fatality) have been reported from 45 countries. 1 Although these numbers are small compared with those in United States or Europe, the WHO recently estimated that up to 190,000 people could die of COVID-19 in Africa if the pandemic is not controlled. 2 These projections are threatening the already overstretched health services in Africa, where governments have been implementing mitigating strategies to flatten epidemic curves at manageable levels. These include education, personal hygiene practices, social distancing, travel bans, and partial or total lockdowns. 3 However, as lockdowns and social distancing measures are currently being lifted in stages by most African countries, governments will need to ensure that public health infrastructure and needed resources are put in place for community surveillance to identify cases and clusters of new infections through active case finding, large-scale testing, and contact tracing. Cost-efficient testing strategies with rapid turnaround and community-based contact-tracing approaches are cornerstones for containment during epidemics. To do so at scale and over the anticipated prolonged course of this pandemic, African countries will need to capitalize on digital health innovations. 4–6 The Global System for Mobile Communication Association reports that 50% of Africans own mobile phones and that 39% are internet-connected, numbers which are rapidly increasing, and approach 80% access when phone-sharing is considered. 7 Mobile phone technology (mHealth) platforms are effective in improving service delivery and outcomes for many health conditions in Africa and globally, including HIV infection, tuberculosis, and chronic noncommunicable diseases. 4–7 In the context of COVID-19, mHealth solutions offer opportunities to directly support public education, case management, and contact tracing, and to perhaps even provide geolocation and exposure notification. 7,8 With the support of global mobile technology companies and small and medium enterprises within Africa, mHealth offers opportunities ranging from text messaging to mobile apps to mitigate the spread of COVID-19. The use of mobile phones reduces the need for physical contact, exchange of materials, and movement by health workers, and thus maximizes safety. Several ongoing digital and mobile initiatives related to COVID-19 have been identified across Africa (Figure 1). District Health Information Software 2 is an open-source, web-based health management information system platform already used by 67 low- and middle-income countries. District Health Information Software 2 has a COVID-19–specific application package that several African countries are using for field data collection. 9 In Rwanda and Uganda, the WelTel virtual care system serves as a real-time remote monitoring platform. COVID-19 cases and contacts in home isolation receive semi-automated daily text message check-ins via SMS for 2 weeks using an open language format, allowing self-reporting of new symptoms or issues. Responses are viewed by health officials on a dashboard, and patients are triaged much faster than would be the case with traditional field outreach or telephone calls, saving critical human resource capacity. Novel natural language processing computing tools promise to reveal insights into the issues that patients face during home quarantine. The provision of monitoring packaged with interactive support helps people undertake home isolation/quarantine most effectively. 10 In Ghana, a short USSD code (*920*222#) dialed on mobile phones allows residents to respond electronically to questions about their symptoms, who they have been in contact with, and their travel history. The Opine Health Assistant compiles the results into maps and graphs to make it easier to understand, monitor, and share. 11 In Senegal, SMS services are used to broadcast good hygiene practices to rural communities to disrupt the spread of COVID-19. 12 In South Africa, community screening, referral for testing, and communication of results of using an mHealth platform are being rapidly expanded to more than 28,000 trained community health workers. 13 Figure 1. Illustrative COVID-19 mHealth initiatives across Africa (not exhaustive). DHIS2 = District Health Information Software 2. Mobile phones and apps also support livelihoods and enable remote access to critical services such as education and food. In Kenya, transaction fees for using M-PESA, a cashless, mobile money platform with 20 million users, have been waived to provide a safe method by which to transfer funds within community settings. In South Africa, mobile data costs of accessing some teaching and learning websites have been waived by major cellphone providers to ensure that primary and secondary school and university students can continue to access learning materials. Globally, mobile counseling, support hotline, and social media platforms are assisting with public health information as well as mental health counseling, food relief, domestic violence concerns, and other support. Government and private alignment within these platforms should be encouraged, as oversight by public health agencies will ensure accurate content. In conclusion, there appears to be a limited window of opportunity in which to contain the spread of COVID-19 in Africa and keep economies afloat. There is a significant body of innovation and evidence to inform mHealth best practices that have emerged from Africa over the past decade. 14–16 mHealth may be a game changer if it is introduced swiftly and widely in this pandemic. To succeed, barriers to access to and use of mobile phones and the latest technologies need to be defined, and there must be cooperation among all stakeholders to enable rapid deployment and scale-up of promising or evidence-based solutions. If mHealth is rigorously implemented, scaled-up, and evaluated through implementation science, then Africa will reap the benefits of this technology for the remainder of the COVID-19 crisis and be better positioned for future pandemics and for improving all aspects of public health.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: not found

          Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.

          Mobile (cell) phone communication has been suggested as a method to improve delivery of health services. However, data on the effects of mobile health technology on patient outcomes in resource-limited settings are limited. We aimed to assess whether mobile phone communication between health-care workers and patients starting antiretroviral therapy in Kenya improved drug adherence and suppression of plasma HIV-1 RNA load. WelTel Kenya1 was a multisite randomised clinical trial of HIV-infected adults initiating antiretroviral therapy (ART) in three clinics in Kenya. Patients were randomised (1:1) by simple randomisation with a random number generating program to a mobile phone short message service (SMS) intervention or standard care. Patients in the intervention group received weekly SMS messages from a clinic nurse and were required to respond within 48 h. Randomisation, laboratory assays, and analyses were done by investigators masked to treatment allocation; however, study participants and clinic staff were not masked to treatment. Primary outcomes were self-reported ART adherence (>95% of prescribed doses in the past 30 days at both 6 and 12 month follow-up visits) and plasma HIV-1 viral RNA load suppression (<400 copies per mL) at 12 months. The primary analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, NCT00830622. Between May, 2007, and October, 2008, we randomly assigned 538 participants to the SMS intervention (n=273) or to standard care (n=265). Adherence to ART was reported in 168 of 273 patients receiving the SMS intervention compared with 132 of 265 in the control group (relative risk [RR] for non-adherence 0·81, 95% CI 0·69-0·94; p=0·006). Suppressed viral loads were reported in 156 of 273 patients in the SMS group and 128 of 265 in the control group, (RR for virologic failure 0·84, 95% CI 0·71-0·99; p=0·04). The number needed to treat (NNT) to achieve greater than 95% adherence was nine (95% CI 5·0-29·5) and the NNT to achieve viral load suppression was 11 (5·8-227·3). Patients who received SMS support had significantly improved ART adherence and rates of viral suppression compared with the control individuals. Mobile phones might be effective tools to improve patient outcome in resource-limited settings. US President's Emergency Plan for AIDS Relief. Copyright © 2010 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial

            Summary Background As mobile phone access continues to expand globally, opportunities exist to leverage these technologies to support demand for immunisation services and improve vaccine coverage. We aimed to assess whether short message service (SMS) reminders and monetary incentives can improve immunisation uptake in Kenya. Methods In this cluster-randomised controlled trial, villages were randomly and evenly allocated to four groups: control, SMS only, SMS plus a 75 Kenya Shilling (KES) incentive, and SMS plus 200 KES (85 KES = USD$1). Caregivers were eligible if they had a child younger than 5 weeks who had not yet received a first dose of pentavalent vaccine. Participants in the intervention groups received SMS reminders before scheduled pentavalent and measles immunisation visits. Participants in incentive groups, additionally, received money if their child was timely immunised (immunisation within 2 weeks of the due date). Caregivers and interviewers were not masked. The proportion of fully immunised children (receiving BCG, three doses of polio vaccine, three doses of pentavalent vaccine, and measles vaccine) by 12 months of age constituted the primary outcome and was analysed with log-binomial regression and General Estimating Equations to account for correlation within clusters. This trial is registered with ClinicalTrials.gov, number NCT01878435. Findings Between Oct 14, 2013, and Oct 17, 2014, we enrolled 2018 caregivers and their infants from 152 villages into the following four groups: control (n=489), SMS only (n=476), SMS plus 75 KES (n=562), and SMS plus 200 KES (n=491). Overall, 1375 (86%) of 1600 children who were successfully followed up achieved the primary outcome, full immunisation by 12 months of age (296 [82%] of 360 control participants, 332 [86%] of 388 SMS only participants, 383 [86%] of 446 SMS plus 75 KES participants, and 364 [90%] of 406 SMS plus 200 KES participants). Children in the SMS plus 200 KES group were significantly more likely to achieve full immunisation at 12 months of age (relative risk 1·09, 95% CI 1·02–1·16, p=0·014) than children in the control group. Interpretation In a setting with high baseline immunisation coverage levels, SMS reminders coupled with incentives significantly improved immunisation coverage and timeliness. Given that global immunisation coverage levels have stagnated around 85%, the use of incentives might be one option to reach the remaining 15%. Funding Bill & Melinda Gates Foundation.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found
              Is Open Access

              Sub-Saharan Africa—the new breeding ground for global digital health

                Bookmark

                Author and article information

                Journal
                Am J Trop Med Hyg
                Am. J. Trop. Med. Hyg
                tpmd
                tropmed
                The American Journal of Tropical Medicine and Hygiene
                The American Society of Tropical Medicine and Hygiene
                0002-9637
                1476-1645
                July 2020
                29 May 2020
                29 May 2020
                : 103
                : 1
                : 3-5
                Affiliations
                [1 ]Department of Medicine and Centre for Infectious Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa;
                [2 ]Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
                [3 ]Departments of Epidemiology, Infectious Diseases and Microbiology, Center for Global Health, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania;
                [4 ]Family Clinical Research Unit (FAMCRU), Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa;
                [5 ]Division of Pharmacometrics, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden;
                [6 ]School of Public Health, University of Rwanda, Kigali, Rwanda;
                [7 ]Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium;
                [8 ]Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom;
                [9 ]National Institute for Health Research Biomedical Research Centre, University College London Hospitals, London, United Kingdom;
                [10 ]Division of Infectious Diseases, Department of Medicine, University of British of Columbia, Vancouver, Canada
                Author notes
                [* ]Address correspondence to Jean B. Nachega, Departments of Epidemiology Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health and Center for Global Health, 130 DeSoto St., A530, Pittsburgh, PA 15261. E-mail: jbn16@ 123456pitt.edu

                Disclosure: J. B. N. is also a coprincipal investigator of TOGETHER, an adaptive randomized clinical trial of novel agents for treatment of high-risk outpatient COVID-19 patients in South Africa; supported by the Bill & Melinda Gates Foundation; and a member of COVID-19 Scientific Committee of the Democratic Republic of the Congo. R. T. L. is an infectious disease specialist and global health researcher with support from the Canadian Institutes of Health Research, Michael Smith Foundation, for Health Research and Grand Challenges Canada, and is cofounder of the WelTel ( www.weltelhealth.com), as well as a member of the roster of experts for the WHO Task Force for Digital Health. He served on the front lines of the 2003 SARS epidemic and led a consortium on the Ebola outbreak response in 2014. Sir Zumla is co-PI of the Pan-African Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET: https://www.pandora-id.net/) funded by the European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme for Research and Innovation. Sir Zumla is recipient of a National Institutes of Health Research senior investigator award.

                Financial support: J. B. N. is supported by the U.S. National Institutes of Health (NIH) and National Institutes of Allergy and Infectious Diseases (NIAID) (Grant number 5U01AI069521; Stellenbosch University Clinical Trial Unit of AIDS Clinical Trial Group) and NIH Fogarty International Center (FIC), grant numbers 1R25TW011217-01 and 1D43TW010937-01A1).

                Authors’ addresses: Jean B. Nachega, Department of Medicine and Centre for Infectious Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, and Departments of Epidemiology Infectious Diseases and Microbiology, Center for Global Health, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, E-mail: jbn16@ 123456pitt.edu . Rory Leisegang, Family Clinical Research Unit (FAMCRU), Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, and Division of Pharmacometrics, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden, E-mail: rory.leisegang@ 123456gmail.com . Oscar Kallay, School of Public Health, University of Rwanda, Kigali, Rwanda, E-mail: oscar_kallay@ 123456yahoo.fr . Edward J. Mills, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium, E-mail: emills@ 123456mteksciences.com . Alimuddin Zumla, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom, and National Institute for Health Research Biomedical Research Centre, University College London Hospitals, London, United Kingdom, E-mail: a.i.zumla@ 123456gmail.com . Richard T. Lester, Division of Infectious Diseases, Department of Medicine, University of British of Columbia, Vancouver, Canada, E-mail: rich@ 123456weltel.org .

                Article
                tpmd200506
                10.4269/ajtmh.20-0506
                7356462
                32476643
                9f841dba-d45e-4591-90f7-431f2f9e3c5f
                © The American Society of Tropical Medicine and Hygiene

                This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 18 May 2020
                : 21 May 2020
                Page count
                Pages: 3
                Categories
                Editorial

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article